Global bariatric surgery devices market is expected to reach USD 2.8
billion by 2022, according to a new report by Grand View Research Inc. The
growing incidence rate of obesity has led to many government initiatives at
regional as well as global level to increase the awareness related to obesity
and undertake various incidence curbing action plans. For instance, the South
Wales government launched the NSW Healthy Eating and Active Living Strategy
2013-2018 for preventing obesity.
In addition, to strategic planning, the governments of developed nations
are also funding universities to design strategic interventions to control the
rising obesity. For the year 2014, New Zealand invested USD 40 million for its
Healthy Families NZ anti-obesity initiative.
The demand for non-invasive surgeries is also increasing, as non-invasive
surgeries save time, cost, and decrease hospital stay. Governments are also
encouraging the use of more incisionless surgeries in order to decrease the
cases of infection. For instance, in July 2015, the FDA approved a balloon
device, where the balloon is directly swallowed through mouth using a sterile
solution.
In depth research report
on Bariatric Surgery Market
Further key findings from
the report suggest:
·
Gastric bypass surgery dominated the market in 2014 due to its early
adoption since 1960 and the fact that it is the combination of both restrictive
and malabsorptive procedures. This minimally invasive surgery offers weight
loss by small incision on the belly and is preferred in patients with diabetes
and gastric reflux issues.
·
The sleeve gastrectomy surgery is expected to witness rapid rise in
demand owing to, the procedure's incision-less nature. The fact that the
procedure does not involve re-routing the intestine is also likely to drive
segment growth. With the FDA approval of ReShape balloon, there has been a
recent FDA filing for Elipse device, which is swallowed and gets excreted
naturally after four months.
·
North America was the largest regional market with revenue share
estimated at over 50% owing to, the presence of market players introducing
continuously innovative technologies to improve patient care. In addition,
North America has the highest population with obesity incidences. In 2013, the
Medicaid-covered costs related to obesity ranged from USD 5.0 million to USD
1.3 billion.
·
Europe was the second largest market in 2014. High obesity rates coupled
with high penetration of technologically advanced procedures are some high
impact rendering regional drivers. Favorable government initiatives are also
expected to play pivotal roles in market growth. For instance, the German
Federal Ministry of Education and Research (BMBF) formed two funding research
programs namely the Competence Network Obesity and Integrated Research and
Treatment Center (IFB) Adiposity Diseases with budgets allocated at around USD
26 million for 2012-2015.
·
Asia Pacific followed North America in terms of obesity and overweight
prevalence. This coupled with the
presence of large untapped opportunities is expected to help the Asia Pacific
bariatric surgery market register the fastest growth over the forecast period.
Moreover, countries like India are now serving as medical tourism destinations
by touting affordable procedure costs.
·
Industry contributors are striving to change the traditional methods of
performing surgeries and innovating newer techniques or devices helping
surgeons perform the procedures in an effective manner. In June 2015, Medtronic
launched GastriSail, a device for sleeve gastrectomy. The device changed the
traditional method of using three devices, thus reducing infection and
irritation.
·
Manufacturers are also conducting collaborative exercises to study the
effect of surgeries on co-morbidities. For instance, In May 2014, GI Dynamics
Inc. collaborated with GSK, to study endobarrier induced changes in bile acid,
responsible for controlling energy and glucose homeostasis. In addition to
this, in June 2015, Ethicon, invested around USD 3.2 million. The investment
was to study the effect of bariatric surgery on Type 2 diabetes and obesity.
·
Some key players of this market include Covidien Plc, Intuitive Surgical
Inc., TransEnterix Inc., Allergan Inc., USGI Medical Inc., Semiled Ltd., Cousin
Biotech, GI Dynamics Inc., Johnson and Johnson and Mediflex Surgical Product.
Grand View Research has segmented the global bariatric surgery market on
the basis of procedures, devices and regions:
Bariatric Surgery
Procedures Outlook (Revenue, USD Million, 2012 - 2022)
·
Adjustable Gastric Band (AGB)
·
Vertical Sleeve Gastrectomy (VSG)
·
Roux-en-Y Gastric Bypass (RYGB)
·
Biliopancreatic Diversion with a Duodenal Switch (BPD-DS)
Bariatric Surgery Devices
Outlook (Revenue, USD Million, 2012 - 2022)
·
Adjustable Gastric Bands
·
Implantable Gastric Simulators
·
Gastric Surgery Clamps
·
Trocars
·
Intragastric Balloons
·
Surgical Staples
·
Clip Appliers
·
Sutures
Bariatric Surgery
Regional Outlook (Revenue, USD Million, 2012 - 2022)
·
North America (U.S. & Canada)
·
Europe
o
UK
o
Germany
o
France
o
Rest of Europe
·
Asia Pacific
o
India
o
Japan
o
China
o
Rest of Asia Pacific
·
Latin America
o
Brazil
o
Mexico
o
Rest of Latin America
·
MEA
o
South Africa
o
Rest of MEA
Browse more research
reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment